Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110

Anticancer activities of histone deacetylase inhibitors

Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919

Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen

Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758

Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice

Ferrante, R. J., Kubilus, J. K., Lee, J.-H., Ryu, H., Beesen, A. A., Zucker, B., Smith, K., Kowall, N. W., Ratan, R. R., Luthi‐Carter, R., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09418.2003 · Cited by 705

Histone Deacetylase Inhibitors Exhibit Anti-Inflammatory and Neuroprotective Effects in a Rat Permanent Ischemic Model of Stroke: Multiple Mechanisms of Action

Kim, H. J., Rowe, M. K., Ren, M., Hong, J., Chen, P.-S., & Chuang, D. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120188 · Cited by 560

Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis

Rossi, A. G., Sawatzky, D. A., Walker, A., Ward, C., Sheldrake, T. A., Riley, N. A., Caldicott, A., Martínez‐Losa, M., Walker, T. R., Duffin, R., et al. (2006) · Nature Medicine · doi:10.1038/nm1468 · Cited by 506

Microglial activation correlates with severity in Huntington disease: A clinical and PET study

Pavese, N., Gerhard, A., Tai, Y. F., Ho, A. K., Turkheimer, F., Barker, R. A., Brooks, D. J., & Piccini, P. (2006) · Neurology · doi:10.1212/01.wnl.0000222734.56412.17 · Cited by 462

Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease

Gárdián, G., Browne, S. E., Choi, D., Klivènyi, P., Gregorio, J., Kubilus, J. K., Ryu, H., Langley, B. C., Ratan, R. R., Ferrante, R. J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410210200 · Cited by 456

Regulation of inflammation by short chain fatty acids

Vinolo, M. A. R., Rodrigues, H. G., Nachbar, R. T., & Curi, R. (2011) · Nutrients · doi:10.3390/nu3100858 · Cited by 1,724

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases

Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381

The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis

Stilling, R. M., van de Wouw, M., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.06.011 · Cited by 891

Multiple roles of HDAC inhibition in neurodegenerative conditions

Chuang, D.-M., Leng, Y., Marinova, Z., Kim, H.-J., & Chiu, C.-T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.002 · Cited by 676

The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders

Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., & Quevedo, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.018 · Cited by 594

Valproic acid in pregnancy: how much are we endangering the embryo and fetus?

Ornoy, A. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.014 · Cited by 526

Molecular and Therapeutic Potential and Toxicity of Valproic Acid

Chateauvieux, S., Morceau, F., Dicato, M., & Diederich, M. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/479364 · Cited by 526

Microbiome–microglia connections via the gut–brain axis

Abdel-Haq, R., Schlachetzki, J. C. M., Glass, C. K., & Mazmanian, S. K. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180794 · Cited by 471

Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency

Shen, S., Sandoval, J., Swiss, V. A., Li, J., Dupree, J. L., Franklin, R. J. M., & Casaccia‐Bonnefil, P. (2008) · Nature Neuroscience · doi:10.1038/nn.2172 · Cited by 499

Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives

Dias, M. F., Joo, K., Kemp, J. A., Fialho, S. L., Silva‐Cunha, A., Woo, S. J., & Kwon, Y. J. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.004 · Cited by 437

Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder

Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404

The epigenetics of aging and neurodegeneration

Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381

Epigenetic regulation of gene expression in physiological and pathological brain processes

Gräff, J., Kim, D., Dobbin, M. M., & Tsai, L.-H. (2011) · Physiological Reviews · doi:10.1152/physrev.00012.2010 · Cited by 373

Microglia, Lifestyle Stress, and Neurodegeneration

Madore, C., Yin, Z., Leibowitz, J. A., & Butovsky, O. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.003 · Cited by 313

The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease

Morris, G., Berk, M., Carvalho, A. F., Caso, J. R., Sanz, Y., Walder, K. R., & Maes, M. H. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0004-2 · Cited by 318

The influence of microglia on the pathogenesis of Parkinson's disease

Long-Smith, C. M., Sullivan, A. M., & Nolan, Y. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.08.001 · Cited by 302

The Impact of Systemic Inflammation on Alzheimer’s Disease Pathology

Xie, J., Van Hoecke, L., & Vandenbroucke, R. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.796867 · Cited by 324

HDAC inhibitor sodium butyrate-mediated epigenetic regulation enhances neuroprotective function of microglia during ischemic stroke

Patnala, R., Arumugam, T. V., Gupta, N., & Dheen, S. T. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0149-z · Cited by 278

The human side of microglia

Smith, A. M., & Dragunow, M. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.12.001 · Cited by 256

Epigenetic mechanisms in Alzheimer's disease

Mastroeni, D., Grover, A., Delvaux, E., Whiteside, C. M., Coleman, P. D., & Rogers, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.017 · Cited by 263

Ageing and neurodegenerative diseases

Hung, C.-W., Chen, Y., Hsieh, W.-L., Chiou, S., & Kao, C.-L. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.006 · Cited by 257

Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection

Monti, B., Polazzi, E., & Contestabile, A. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902010095 · Cited by 244

Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach

Krug, A. K., Kolde, R., Gaspar, J. A., Rempel, E., Balmer, N. V., Meganathan, K., Vojnits, K., Baquié, M., Waldmann, T., Enseñat‐Waser, R., et al. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0967-3 · Cited by 228

The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials

Duan, H., Wang, L., Huangfu, M., & Li, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115276 · Cited by 252

Epigenetic targeting of histone deacetylase: Therapeutic potential in Parkinson's disease?

Harrison, I. F., & Dexter, D. T. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.05.010 · Cited by 233

Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis

Jing, Y., Yu, Y., Bai, F., Wang, L., Yang, D., Zhang, C., Qin, C., Yang, M., Zhang, D., Zhu, Y., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01007-y · Cited by 234

Sodium Butyrate Abolishes Lipopolysaccharide-Induced Depression-like Behaviors and Hippocampal Microglial Activation in Mice

Yamawaki, Y., Yoshioka, N., Nozaki, K., Ito, H., Oda, K., Harada, K., Shirawachi, S., Asano, S., Aizawa, H., Yamawaki, S., et al. (2018) · Brain Research · doi:10.1016/j.brainres.2017.12.004 · Cited by 204

Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage

Paiva, I., Pinho, R., Pavlou, M. A., Hennion, M., Wales, P., Schütz, A.-L., Rajput, A., Szegő, É. M., Kerimoglu, C., Gerhardt, E., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx114 · Cited by 185

Valproic Acid is Neuroprotective in the Rotenone Rat Model of Parkinson’s Disease: Involvement of α-Synuclein

Monti, B., Gatta, V., Piretti, F., Raffaelli, S. S., Virgili, M., & Contestabile, A. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9090-5 · Cited by 174

Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders

Grayson, D. R., Kundakovic, M., & Sharma, R. P. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061333 · Cited by 171

Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation

Wu, H.-M., Tzeng, N., Li, Q., Wei, S., Hu, X., Chen, S., Rawls, S. M., Flood, P. M., Hong, J., & Lu, R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.64 · Cited by 174

The effects of butyrate enemas on visceral perception in healthy volunteers

Vanhoutvin, S. A. L. W., Troost, F. J., Kilkens, T. O. C., Lindsey, P. J., Hamer, H. M., Jonkers, D. M. A. E., Venema, K., & Brummer, R. ‐. M. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01324.x · Cited by 171

Intestinal Microbiota in Patients with Spinal Cord Injury

Gungor, B., Adıgüzel, E., Gürsel, İ., Yılmaz, B., & Gürsel, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145878 · Cited by 173

Epigenetic Control of Sexual Differentiation of the Bed Nucleus of the Stria Terminalis

Murray, E. K., Hien, A., Vries, G. J. D., & Forger, N. G. (2009) · Endocrinology · doi:10.1210/en.2009-0458 · Cited by 166

Histone Deacetylase Inhibitors for Treating a Spectrum of Diseases Not Related to Cancer

Dinarello, C. A., Fossati, G., & Mascagni, P. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00116 · Cited by 160

Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner

Schmidtner, A. K., Slattery, D. A., Gläsner, J., Hiergeist, A., Gryksa, K., Malik, V. A., Hellmann-Regen, J., Heuser, I., Baghai, T. C., Gessner, A., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0556-9 · Cited by 153

Histone deacetylase inhibitors suppress interleukin-1β-induced nitric oxide and prostaglandin E2 production in human chondrocytes

Chabane, N., Zayed, N., Afif, H., Endam, L. M., Benderdour, M., Boileau, C., Martel‐Pelletier, J., Pelletier, J., Duval, N., & Fahmi, H. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.03.009 · Cited by 158

Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation

Kaminska, B., Mota, M., & Pizzi, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.026 · Cited by 161

The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats

Park, M. J., & Sohrabji, F. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0765-6 · Cited by 150

Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo

Faraco, G., Pittelli, M. G., Cavone, L., Fossati, S., Porcu, M., Mascagni, P., Fossati, G., Moroni, F., & Chiarugi, A. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.019 · Cited by 141

HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats.

Zhang, B., West, E., Van, K. C., Gurkoff, G. G., Zhou, J., Zhang, X.-M., Kozikowski, A., & Lyeth, B. G. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.085 · Cited by 138

Inflammation in ALS and SMA: Sorting out the good from the evil

Papadimitriou, D. A., Verche, V. L., Jacquier, A., Ikiz, B., Przedborski, S., & Ré, D. B. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.005 · Cited by 137

HDAC inhibitors and neurodegeneration: At the edge between protection and damage

Dietz, K. C., & Casaccia, P. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.011 · Cited by 128

Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis

Yoo, Y.-E., & Ko, C. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.003 · Cited by 122

Histone Deacetylases and Mood Disorders: Epigenetic Programming in Gene‐Environment Interactions

Machado‐Vieira, R., Ibrahim, L. A., & Zarate, C. A. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00203.x · Cited by 121

Tuning acetylation levels with HAT activators: Therapeutic strategy in neurodegenerative diseases

Selvi, B. R., Cassel, J., Kundu, T. K., & Boutillier, A. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.08.012 · Cited by 121

Epigenetic regulation in Parkinson’s disease

Labbé, C., Lorenzo‐Betancor, O., & Ross, O. A. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1590-9 · Cited by 118

Pathological histone acetylation in Parkinson’s disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition

Harrison, I. F., Smith, A. D., & Dexter, D. T. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.12.037 · Cited by 115

Sodium valproate: an old drug with new roles

Nalivaeva, N. N., Belyaev, N. D., & Turner, A. J. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.002 · Cited by 115

Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition

Kidd, S. K., & Schneider, J. S. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.041 · Cited by 113

Acetyltransferases (HATs) as Targets for Neurological Therapeutics

Schneider‐Anthony, A., Chatterjee, S., Bousiges, O., Selvi, B. R., Swaminathan, A., Cassel, R., Blanc, F., Kundu, T. K., & Boutillier, A. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0204-7 · Cited by 120

Microbiota–Host Transgenomic Metabolism, Bioactive Molecules from the Inside

Turroni, S., Brigidi, P., Cavalli, A., & Candela, M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00244 · Cited by 111

Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: Restoring effects of inhibitors of HDACs, p38 MAPK and GSK3β

Correa, F., Mallard, C. E., Nilsson, M., & Sandberg, M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.06.016 · Cited by 106

Potential Roles of HDAC Inhibitors in Mitigating Ischemia-induced Brain Damage and Facilitating Endogenous Regeneration and Recovery

Fessler, E. B., Chibane, F. L., Wang, Z., & Chuang, D. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319280009 · Cited by 107

Long-term effects of early life stress exposure: Role of epigenetic mechanisms

Silberman, D. M., Acosta, G. B., & Zubilete, M. A. Z. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.033 · Cited by 114

Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application

Watkins, C. C., Sawa, A., & Pomper, M. G. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.119 · Cited by 100

Epigenetic regulation of reelin and brain-derived neurotrophic factor genes in long-term potentiation in rat medial prefrontal cortex

Sui, L., Wang, Y., Ju, L.-H., & Chen, M. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2012.03.007 · Cited by 109

Sexually dimorphic effects of prenatal exposure to lipopolysaccharide, and prenatal and postnatal exposure to propionic acid, on acoustic startle response and prepulse inhibition in adolescent rats: Relevance to autism spectrum disorders

Foley, K. A., MacFabe, D. F., Kavaliers, M., & Ossenkopp, K. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.09.032 · Cited by 100

Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

Kidd, S. K., & Schneider, J. S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.010 · Cited by 96

Epigenetic Landscape of Parkinson's Disease: Emerging Role in Disease Mechanisms and Therapeutic Modalities

Kaidery, N. A., Tarannum, S., & Thomas, B. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0211-8 · Cited by 93

Drugs interfering with mitochondrial disorders

Finsterer, J., & Segall, L. (2009) · Drug and Chemical Toxicology · doi:10.3109/01480540903207076 · Cited by 92

Current trends in protein acetylation analysis

Diallo, I., Seve, M., Cunin, V., Minassian, F., Poisson, J., Michelland, S., & Bourgoin‐Voillard, S. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1559061 · Cited by 93

Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury

Fleiss, B., Nilsson, M. K. L., Blomgren, K., & Mallard, C. E. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-70 · Cited by 88

Valproic acid as a promising agent to combat Alzheimer's disease

Zhang, X., Li, X., & Zhang, H. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.09.003 · Cited by 86

Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats

Zhang, Z., Zhang, Z., Wu, Y., & Schluesener, H. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.013 · Cited by 86

Epigenetics in Parkinson’s Disease

Pavlou, M. A. S., & Outeiro, T. F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_19 · Cited by 85

Epigenetic programming of neurodegenerative diseases by an adverse environment

Babenko, O., Kovalchuk, I., & Metz, G. A. S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.038 · Cited by 80

HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation.

Kim, H. J., & Chuang, D. (2014) · Europe PMC (PubMed Central) · Cited by 79

The Therapeutic Potential of HDAC Inhibitors in the Treatment of Multiple Sclerosis

Faraco, G., Cavone, L., & Chiarugi, A. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00077 · Cited by 80

Relationship Between Short-chain Fatty Acids and Parkinson’s Disease: A Review from Pathology to Clinic

Duan, W.-X., Wang, F., Liu, J., & Liu, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01123-9 · Cited by 91

Valproic acid improves outcome after rodent spinal cord injury: Potential roles of histone deacetylase inhibition

Lv, L., Sun, Y., Han, X., Xu, C., Tang, Y., & Dong, Q. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.040 · Cited by 77

Valproic Acid for Treatment of Hyperactive or Mixed Delirium: Rationale and Literature Review

Sher, Y. I., Cramer, A. C. M., Ament, A., Lolak, S., & Maldonado, J. R. (2015) · Psychosomatics · doi:10.1016/j.psym.2015.09.008 · Cited by 76

Enhancement of Autophagy by Histone Deacetylase Inhibitor Trichostatin A Ameliorates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats

Shao, A., Wang, Z., Wu, H., Dong, X., Li, Y. H., Tu, S., Tang, J., Zhao, M., Zhang, J., & Hong, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8986-0 · Cited by 74

Putting the ‘HAT’ back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions

Sleiman, S. F., Basso, M., Mahishi, L., Kozikowski, A. P., Donohoe, M. E., Langley, B. C., & Ratan, R. R. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902810345 · Cited by 77

Sodium Butyrate, a Histone Deacetylase Inhibitor, Exhibits Neuroprotective/Neurogenic Effects in a Rat Model of Neonatal Hypoxia-Ischemia

Ziemka‐Nałęcz, M., Jaworska, J., Sypecka, J., Polowy, R., Filipkowski, R. K., & Zalewska, T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0049-2 · Cited by 75

Retinitis Pigmentosa: Review of Current Treatment

Wang, A. L., Knight, D. K., Vu, T.-T. T., & Mehta, M. C. (2018) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000256 · Cited by 73

Epigenetics and the Modulation of Neuroinflammation

Garden, G. A. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0207-4 · Cited by 70

Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells

Nahman, S., Belmaker, R., & Azab, A. N. (2011) · Innate Immunity · doi:10.1177/1753425911421512 · Cited by 73

HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells

Wang, Y., Wang, X., Liu, L., & Wang, X. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.037 · Cited by 71

Genome‐Wide Association Study Identifies Risk Loci for Cluster Headache

O’Connor, E., Fourier, C., Ran, C., Sivakumar, P., Liesecke, F., Southgate, L., Harder, A. V. E., Vijfhuizen, L. S., Yip, J., Giffin, N., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26150 · Cited by 71

Infectious diseases, autoantibodies, and autoimmunity

Johnson, D., & Jiang, W. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102962 · Cited by 77

Targeting Histone Deacetylases: A Novel Approach in Parkinson’s Disease

Sharma, S., & Taliyan, R. (2015) · Parkinson s Disease · doi:10.1155/2015/303294 · Cited by 71

Valproic acid attenuates inflammation in experimental autoimmune neuritis

Zhang, Z., Zhang, Z. Y., Fauser, U., & Schluesener, H. J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8521-4 · Cited by 68

Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation

Peña‐Altamira, E., Prati, F., Massenzio, F., Virgili, M., Contestabile, A., Bolognesi, M. L., & Monti, B. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1121237 · Cited by 70

Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson's disease: A bench-to-bedside translational approach

Liu, J., Lv, X., Ye, T., Zhao, M., Chen, Z., Zhang, Y., Yang, W., Xie, H., Lü, Z., Chen, L., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.01.010 · Cited by 75

Novel biomolecule lycopene-reduced graphene oxide-silver nanoparticle enhances apoptotic potential of trichostatin A in human ovarian cancer cells (SKOV3)

Zhang, X., Huang, F., Zhang, G., Bai, D.-P., Massimo, D. F., Huang, Y., & Gurunathan, S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s144161 · Cited by 68

Pharmacology of epigenetics in brain disorders

Narayan, P. J., & Dragunow, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00526.x · Cited by 67

Spinal cord injury-induced gut dysbiosis influences neurological recovery partly through short-chain fatty acids

Jing, Y., Yang, D., Bai, F., Wang, Q., Zhang, C., Yan, Y., Li, Z., Li, Y., Chen, Z., Li, J., et al. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00466-5 · Cited by 72

Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results

Berendsen, S., Broekman, M. L. D., Seute, T., Snijders, T. J., van Es, C. A., Vos, F. D., Regli, L., & Robe, P. A. J. T. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.694425 · Cited by 69

Inhibition of histone deacetylase 1 or 2 reduces induced cytokine expression in microglia through a protein synthesis independent mechanism

Durham, B. S., Grigg, R., & Wood, I. C. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14144 · Cited by 67

Sodium Butyrate and Indole-3-propionic Acid Prevent the Increase of Cytokines and Kynurenine Levels in LPS-induced Human Primary Astrocytes

Garcez, M. L., Tan, V. X., Heng, B., & Guillemin, G. J. (2020) · International Journal of Tryptophan Research · doi:10.1177/1178646920978404 · Cited by 64

Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases

Teijido, Ó., & Cacabelos, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103199 · Cited by 69

Valproic Acid: A New Candidate of Therapeutic Application for the Acute Central Nervous System Injuries

Chen, S., Wu, H., Klebe, D. W., Hong, Y., & Zhang, J. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1241-2 · Cited by 66

Central and peripheral regulations mediated by short-chain fatty acids on energy homeostasis

Luo, P., Lednovich, K., Xu, K., Nnyamah, C., Layden, B. T., & Xu, P. (2022) · Translational research · doi:10.1016/j.trsl.2022.06.003 · Cited by 62

Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson’s Disease Are Related to Its Anti-Inflammatory Effects

Lima, F. A. V., Joventino, I. P., Joventino, F. P., de Almeida, A. C., Neves, K. R. T., do Carmo, M. R. S., Leal, L. K. A. M., de Andrade, G. M., & Viana, G. S. D. B. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2379-5 · Cited by 63

Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells.

Biermann, J., Boyle, J., Pielen, A., & Lagrèze, W. A. (2011) · PubMed Central · Cited by 62

NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease

Suo, H., Wang, P., Tong, J., Cai, L., Liu, J., Huang, D., Huang, L., Wang, Z., Huang, Y., Xu, J., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.015 · Cited by 62

Histone H3 acetylation in the postmortem Parkinson’s disease primary motor cortex

Gebremedhin, K. G., & Rademacher, D. J. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.05.060 · Cited by 62

Epigenetic mechanisms in the development and maintenance of dopaminergic neurons

van Heesbeen, H. J., Mesman, S., Veenvliet, J. V., & Smidt, M. P. (2013) · Development · doi:10.1242/dev.089359 · Cited by 61

Targeting the blood–brain barrier to delay aging-accompanied neurological diseases by modulating gut microbiota, circadian rhythms, and their interplays

Wang, Y., Du, W., Hu, X., Yu, X., Guo, C., Jin, X., & Wang, W. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.08.009 · Cited by 58

Histone deacetylase inhibition leads to neuroprotection through regulation on glial function

Wu, X., Li, S., Wu, Q., Peng, Y., Yu, D., Wang, H., Chui, D., & Zhao, J. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-s1-p49 · Cited by 18

Histone deacetylase inhibitors valproic acid and sodium butyrate enhance prostaglandins release in lipopolysaccharide-activated primary microglia

Singh, V., Bhatia, H. S., Kumar, A., de Oliveira, A. C. P., & Fiebich, B. L. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.01.037 · Cited by 53

Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia

Peng, G.-S., Li, G., Tzeng, N., Chen, P.-S., Chuang, D., Hsu, Y., Yang, S., & Hong, J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.10.021 · Cited by 169

Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons

Kanai, H., Sawa, A., Chen, R.-W., Leeds, P. R., & Chuang, D. M. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500269 · Cited by 124

Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons

Wu, X., Chen, P. S., Dallas, S., Wilson, B. C., Block, M. L., Wang, C.-C., Kinyamu, H. K., Lu, N. Z., Gao, X., Leng, Y., et al. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009024 · Cited by 318